RxDoctor Payments Data
★ My doctorsLook up a doctor →

Vinay Aggarwal

Orthopaedic Surgery · New York, NYNPI 1619312584

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (39.9%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Zimmer Biomet accounts for 64.2% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $112,026, more than ten times the $2,119 reported in 2019. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$210,945in general payments, 2019–2025

Across 306 payments — averaging $689.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$135K
  • Davol Inc.$36K
  • Biomerieux Inc$16K
  • Linkbio Corp$14K
  • Smith+Nephew$4K
  • Globus Medical$1K
  • plus $4K from 17 others
$306,632in research payments, 2019–2025

Across 13 payments — averaging $23,587 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$307K

What the payments were for

  • Consulting fees$60,26329%
  • Speaking & faculty fees$40,14119%
  • Travel & lodging$13,8867%
  • Food & beverage$12,5186%
  • Education$84,13740%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Zimmer Biomet199$135,328
Davol Inc.20$36,286
Biomerieux Inc6$16,431
Linkbio Corp10$13,898
Smith+Nephew20$4,117
Globus Medical4$1,060
Stryker11$704
Exactech, Inc.6$676
Synthes GmbH1$500
KCI USA, Inc.4$290
Intellijoint Surgical Inc.2$273
Medtronic2$230
Johnson & Johnson(2 entities)6$219
Sanara Medtech Inc.1$175
Urgo Medical North America, LLC1$171
Medical Device Business Services, Inc.1$147
Novo Nordisk1$125
Solventum Corporation3$119
Molnlycke Health Care US, LLC2$48
Heron Therapeutics, Inc.2$45
Orthalign Inc1$42
AbbVie1$30
Ferring Pharmaceuticals Inc.2$29

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$210,945 in reported general payments places this provider in the 90th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$179,783
Medicare patients
270
Services billed
1,070

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naproxen31$301
Meloxicam84$205
Oxycodone Hcl46$144
Ibuprofen23$111
Tramadol Hcl34$81
Gabapentin11$35

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →